CluenexMolina Healthcare MOH
Molina Healthcare scores weak on business quality (3.9 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What Molina Healthcare does
Molina Healthcare administers government-sponsored health programs, primarily Medicaid, Medicare, and Marketplace plans, collecting premiums from state and federal agencies to pay medical providers for low-income members.
- What it does best
Molina scales low-income managed care efficiently, posting a revenue growth rate of 11.7% that sits in the top quartile of its sector at the 70th percentile. This state-contract focus creates heavy bidding barriers against traditional commercial insurers.
- The main risk
Medical cost ratios can spike unexpectedly and wipe out thin margins, as shown by a net loss of $7.0 million on $44.5 billion of revenue. A single state rate miscalculation damages earnings power instantly.
Quality, check by check
Scored against its own industry, from company filings.
Operating margin sits at a razor-thin 0.7% while return on equity is negative 17%, driven by surging medical costs. Scale does not protect profits here, as higher revenue merely expands low-margin liabilities.
State-level regulatory licenses lock in government-sponsored members, placing its gross margin in the bottom quartile at the 5th sector percentile. Competitors cannot easily enter without established state contracts.
Revenue grew 11.7% to $44.5 billion, continuing a steady multi-year expansion from $19.4 billion in 2020. However, free cash flow has deteriorated from past highs, showing growth is not converting cleanly into cash.
Debt-to-equity sits near 1.0 while interest coverage is thin at 1.4x, meaning debt costs consume most operating earnings. Free cash flow swung from positive highs down to $271 million, pointing to a softening financial cushion.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
No open market buys or unplanned sales by executives or directors.
Our sealed record on MOH
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
Molina Healthcare scores weak on the Cluenex quality check (3.9 of 10), measured against its own industry. Profitability is weak, moat weak, growth steady and financial health weak.
In the last 90 days of SEC Form 4 filings: No open market buys or unplanned sales by executives or directors.
Oct 21, 2026, after the close.
See MOH today
- Today's verdict on MOH, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “Molina Healthcare (MOH)”, https://cluenex.com/stocks/moh/, data as of Oct 10, 2026.